The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing
Open accessPreprint — published as 10.1038/s41586-020-2286-9 · Paper page
Abstract
An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption 1,2 . There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 67 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888
Self-citationA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,067
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
A novel coronavirus outbreak of global health concern
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30185-9 · Cited by 7,700
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., & Mann, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031591 · Cited by 5,180
Comparative Protein Structure Modeling Using Modeller
Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Sali, A. (2006) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0506s15 · Cited by 4,478
Self-citationComparative Protein Structure Modeling Using MODELLER
Webb, B., & Sali, A. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.3 · Cited by 4,316
Self-citationCoronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
Comparative Protein Structure Modeling Using MODELLER
Eswar, N., Webb, B., Marti‐Renom, M. A., Madhusudhan, M. S., Eramian, D., Shen, M., Pieper, U., & Sali, A. (2007) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0209s50 · Cited by 2,846
Self-citationProteomeXchange provides globally coordinated proteomics data submission and dissemination
Vizcaíno, J. A., Deutsch, E. W., Wang, R., Csordas, A., Reisinger, F., Ríos, D., Dianes, J. A., Sun, Z., Farrah, T., Bandeira, N., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2839 · Cited by 2,729
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.-P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Müller, S., Pawson, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.013 · Cited by 1,694
The mutational constraint spectrum quantified from variation in 141,456 humans
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., et al. (2019) · doi:10.1101/531210 · Cited by 1,662
Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., & Hidaka, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34116-x · Cited by 1,484
The BioPlex network: a systematic exploration of the human interactome
Huttlin, E. L., Ting, L., Bruckner, R. J., Gebreab, F., Gygi, M. P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.043 · Cited by 1,425
CORUM: the comprehensive resource of mammalian protein complexes—2009
Ruepp, A., Waegele, B., Lechner, M., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., & Mewes, H.-W. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp914 · Cited by 1,310
Hypothalamic mTOR Signaling Regulates Food Intake
Cota, D., Proulx, K., Smith, K. A. B., Kozma, S. C., Thomas, G., Woods, S. C., & Seeley, R. J. (2006) · Science · doi:10.1126/science.1124147 · Cited by 1,278
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
Wheaton, W. W., Weinberg, S. E., Hamanaka, R. B., Soberanes, S., Sullivan, L. B., Anso, E., Glasauer, A., Dufour, E., Mutlu, G. M., Budigner, G. S., et al. (2014) · eLife · doi:10.7554/elife.02242 · Cited by 1,105
Responding to Covid-19 — A Once-in-a-Century Pandemic?
Gates, B. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003762 · Cited by 1,076
Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5883 · Cited by 1,071
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Zengerle, M., Chan, K.-H., & Ciulli, A. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00216 · Cited by 1,056
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C. (2020) · Nature · doi:10.1038/s41586-020-2332-7 · Cited by 1,010
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
Deutsch, E. W., Csordas, A., Sun, Z., Jarnuczak, A., Perez-Riverol, Y., Ternent, T., Campbell, D. S., Bernal-Llinares, M., Okuda, S., Kawano, S., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw936 · Cited by 865
Mechanisms and enzymes involved in SARS coronavirus genome expression
Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., et al. (2003) · Journal of General Virology · doi:10.1099/vir.0.19424-0 · Cited by 848
The ClinicalTrials.gov Results Database — Update and Key Issues
Zarin, D. A., Tse, T., Williams, R. J., Califf, R. M., & Ide, N. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmsa1012065 · Cited by 838
The PDB_REDO server for macromolecular structure model optimization
Joosten, R. P., Long, F., Murshudov, G. N., & Perrakis, A. (2014) · IUCrJ · doi:10.1107/s2052252514009324 · Cited by 834
PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta
Chaudhury, S., Lyskov, S., & Gray, J. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq007 · Cited by 816
Molecular Evolution of the SARS Coronavirus During the Course of the SARS Epidemic in China
The Chinese SARS Molecular Epidemiology Consortium (2004) · Science · doi:10.1126/science.1092002 · Cited by 775
A deep proteome and transcriptome abundance atlas of 29 healthy human tissues
Wang, D., Eraslan, B., Wieland, T., Hallström, B., Hopf, T., Zolg, D. P., Zecha, J., Asplund, A., Li, L., Meng, C., et al. (2019) · Molecular Systems Biology · doi:10.15252/msb.20188503 · Cited by 750 · cited 1×
“We tested if the interacting human proteins were preferentially highly expressed, at the protein level, in any of 29 human tissues 32 , which identified the lung as the tissue with the highest expression of the prey proteins relative to the average proteome (Fig.”
BackgroundGlobal landscape of HIV–human protein complexes
Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., et al. (2012) · Nature · doi:10.1038/nature10719 · Cited by 731
Self-citationDetermination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713
SAINTexpress: Improvements and additional features in Significance Analysis of INTeractome software
Teo, G., Liu, G., Zhang, J., Nesvizhskii, A. I., Gingras, A.-C., & Choi, H. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2013.10.023 · Cited by 682
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
Škrtić, M., Sriskanthadevan, S., Jhas, B., Gebbia, M., Wang, X., Wang, Z., Hurren, R., Jitkova, Y., Gronda, M., Maclean, N., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.015 · Cited by 678
CORUM: the comprehensive resource of mammalian protein complexes—2019
Giurgiu, M., Reinhard, J., Brauner, B., Dunger-Kaltenbach, I., Fobo, G., Frishman, G., Montrone, C., & Ruepp, A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky973 · Cited by 595
Barretto, N., Jukneliene, D., Ratia, K., Chen, Z., Mesecar, A. D., & Baker, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15189-15198.2005 · Cited by 582
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States
Harcourt, J., Tamin, A., Lu, X., Kamili, S., Sakthivel, S. K., Murray, J., Queen, K., Tao, Y., Paden, C. R., Zhang, J., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2606.200516 · Cited by 542
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
Krämer, O. H., Zhu, P., Ostendorff, H. P., Golebiewski, M., Tiefenbach, J., Peters, M. A., Brill, B., Groner, B., Bach, I., Heinzel, T., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg315 · Cited by 523
Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012) · Journal of Virology · doi:10.1128/jvi.00094-12 · Cited by 515
Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update
Nettleton, J. A., Brouwer, I. A., Geleijnse, J. M., & Hornstra, G. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000455681 · Cited by 510
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., Bliesath, J., Omori, M., Huser, N., Ho, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1893 · Cited by 506
Stress Granules and Processing Bodies in Translational Control
Ivanov, P., Kedersha, N., & Anderson, P. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a032813 · Cited by 496
Coronavirus puts drug repurposing on the fast track
Harrison, C. (2020) · Nature Biotechnology · doi:10.1038/d41587-020-00003-1 · Cited by 470
The structure and functions of coronavirus genomic 3′ and 5′ ends
Yang, D., & Leibowitz, J. L. (2015) · Virus Research · doi:10.1016/j.virusres.2015.02.025 · Cited by 458
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
Faivre, E. J., McDaniel, K. F., Albert, D. H., Mantena, S. R., Plotnik, J. P., Wilcox, D., Zhang, L., Bui, M. H., Sheppard, G. S., Wang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-1930-8 · Cited by 408
Kindrachuk, J., Ork, B., Hart, B. J., Mazur, S., Holbrook, M. R., Frieman, M. B., Traynor, D., Johnson, R. F., Dyall, J., Kuhn, J. H., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03659-14 · Cited by 407
The Physiology of Protein S-acylation
Chamberlain, L. H., & Shipston, M. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00032.2014 · Cited by 406
Matsuda, A., Suzuki, Y., Honda, G., Muramatsu, S., Matsuzaki, O., Nagano, Y., Doi, T., Shimotohno, K., Harada, T., Nishida, E., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206406 · Cited by 395
Hellewell, S. B., Bruce, A., Feinstein, G., Orringer, J., Williams, W., & Bowen, W. D. (1994) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(94)90115-5 · Cited by 390
Shah, P. S., Link, N., Jang, G. M., Sharp, P. P., Zhu, T., Swaney, D. L., Johnson, J. R., Von Dollen, J., Ramage, H. R., Satkamp, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.11.028 · Cited by 380
Self-citationThe inhibition of nucleic acid synthesis by mycophenolic acid
Franklin, T. J., & Cook, J. M. (1969) · Biochemical Journal · doi:10.1042/bj1130515 · Cited by 368
Li, S., Wang, L., Berman, M., Kong, Y.-Y., & Dorf, M. E. (2011) · Immunity · doi:10.1016/j.immuni.2011.06.014 · Cited by 340
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J.-I., & Matsuda, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01043-16 · Cited by 340
Role of HDAC2 in the Pathophysiology of COPD
Barnes, P. J. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163257 · Cited by 318
The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon
Wang, C., Chen, T., Zhang, J., Yang, M., Li, N., Xu, X., & Cao, X. (2009) · Nature Immunology · doi:10.1038/ni.1742 · Cited by 317
Pierre, F., Chua, P. C., O’Brien, S. E., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101251q · Cited by 296
NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK
Xia, X., Cui, J., Wang, H. Y., Zhu, L., Matsueda, S., Wang, Q., Yang, X., Hong, J., Songyang, Z., Chen, Z. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.022 · Cited by 273
Inhibition of Mammalian Mitochondrial Protein Synthesis by Oxazolidinones
McKee, E. E., Ferguson, M., Bentley, A. T., & Marks, T. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01411-05 · Cited by 270
Translation control of the immune checkpoint in cancer and its therapeutic targeting
Xu, Y., Poggio, M., Jin, H. Y., Shi, Z., Forester, C. M., Wang, Y., Stumpf, C. R., Xue, L., Devericks, E., So, L., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0321-2 · Cited by 261
Self-citationStructural insight into allosteric modulation of protease-activated receptor 2
Cheng, R. K. Y., Fiez-Vandal, C., Schlenker, O., Edman, K., Aggeler, B., Brown, D. G., Brown, G. A., Cooke, R. M., Dumelin, C. E., Doré, A. S., et al. (2017) · Nature · doi:10.1038/nature22309 · Cited by 246
Asano, N., Ishii, S., Kizu, H., Ikeda, K., Yasuda, K., Kato, A., Martin, O. R., & Fan, J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01457.x · Cited by 242
A glycine-specific N-degron pathway mediates the quality control of protein N -myristoylation
Timms, R. T., Zhang, Z., Rhee, D. Y., Harper, J. W., Koren, I., & Elledge, S. J. (2019) · Science · doi:10.1126/science.aaw4912 · Cited by 240
Self-citationInhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs
Tan, E. L. C., Ooi, E. E., Lin, C.-Y., Tan, H. C., Ling, A. E., Lim, B., & Stanton, L. W. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1004.030458 · Cited by 237
VSV Disrupts the Rae1/mrnp41 mRNA Nuclear Export Pathway
Faria, P. A., Chakraborty, P., Levay, A., Barber, G. N., Ezelle, H. J., Enninga, J., Arana, C., van Deursen, J., & Fontoura, B. M. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.023 · Cited by 235
Reineke, L. C., & Lloyd, R. E. (2015) · Journal of Virology · doi:10.1128/jvi.02791-14 · Cited by 219
Albrecht, B. K., Gehling, V. S., Hewitt, M. C., Vaswani, R. G., Côté, A., Leblanc, Y., Nasveschuk, C. G., Bellon, S., Bergeron, L., Campbell, R., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01882 · Cited by 212
Self-citationGlobal Mapping of Herpesvirus-Host Protein Complexes Reveals a Transcription Strategy for Late Genes
Davis, Z. H., Verschueren, E., Jang, G. M., Kleffman, K., Johnson, J. R., Park, J., Von Dollen, J., Maher, M. C., Johnson, T., Newton, W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.11.026 · Cited by 203
Self-citationRVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
McLure, K. G., Gesner, E. M., Tsujikawa, L., Kharenko, O. A., Attwell, S., Campeau, E., Wasiak, S., Stein, A., White, A., Fontano, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083190 · Cited by 198
Ryzhakov, G., & Randow, F. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601743 · Cited by 197
QCloud: A cloud-based quality control system for mass spectrometry-based proteomics laboratories
Chiva, C., Olivella, R., Borràs, E., Espadas, G., Pastor, O., Solé, A., & Sabidó, E. (2018) · PLOS ONE · doi:10.1371/journal.pone.0189209 · Cited by 194
Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Sharman, J. L., Campo, B., Cavanagh, D. R., Alexander, S. P. H., Davenport, A. P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz951 · Cited by 191
Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection
Mirrashidi, K. M., Elwell, C. A., Verschueren, E., Johnson, J. R., Frando, A., Von Dollen, J., Rosenberg, O., Gulbahce, N., Jang, G., Johnson, T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.004 · Cited by 189
Self-citationSevere Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations
Chang, L., Zhao, L., Gong, H., Wang, L., & Wang, L. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200839 · Cited by 177
Reich, S. H., Sprengeler, P. A., Chiang, G. G., Appleman, J. R., Chen, J., Clarine, J., Eam, B., Ernst, J. T., Han, Q., Goel, V. K., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01795 · Cited by 175
Tom70 mediates activation of interferon regulatory factor 3 on mitochondria
Liu, X.-Y., Wei, B., Shi, H.-X., Shan, Y.-F., & Wang, C. (2010) · Cell Research · doi:10.1038/cr.2010.103 · Cited by 171
Self-citationHultquist, J. F., Schumann, K., Woo, J. M., Manganaro, L., McGregor, M. J., Doudna, J., Simon, V., Krogan, N. J., & Marson, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.080 · Cited by 170
Self-citationNissinen, E., Lindén, I., Schultz, E., & Pohto, P. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00173538 · Cited by 166
Structure Guided Design of Potent and Selective Ponatinib-Based Hybrid Inhibitors for RIPK1
Najjar, M., Suebsuwong, C., Ray, S. S., Thapa, R. J., Maki, J. L., Nogusa, S., Shah, S., Saleh, D., Gough, P. J., Bertin, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.052 · Cited by 163
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication
Batra, J., Hultquist, J. F., Liu, D., Shtanko, O., Dollen, J. V., Satkamp, L., Jang, G. Μ., Luthra, P., Schwarz, T. M., Small, G. I., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.044 · Cited by 155
Self-citationRamage, H. R., Kumar, G. R., Verschueren, E., Johnson, J. R., Dollen, J. V., Johnson, T. L., Newton, B. W., Shah, P. S., Horner, J. A., Krogan, N. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.028 · Cited by 146
Self-citationATP-Competitive Inhibitors of mTOR: An Update
Schenone, S., Brullo, C., Musumeci, F., Radi, M., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391651 · Cited by 142
Díaz, J. L., Cuberes, R., Berrocal, J., Contijoch, M., Christmann, U., Fernández, A., Port, A., Holenz, J., Buschmann, H., Laggner, C., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3007323 · Cited by 140
Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story
Naffouje, R., Grover, P., Yu, H., Sendilnathan, A., Wolfe, K., Majd, N., Smith, E. P., Takeuchi, K., Senda, T., Kofuji, S., et al. (2019) · Cancers · doi:10.3390/cancers11091346 · Cited by 138
Adapting the Stress Response: Viral Subversion of the mTOR Signaling Pathway
Sage, V. L., Cinti, A., Amorim, R., & Mouland, A. J. (2016) · Viruses · doi:10.3390/v8060152 · Cited by 134
The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon-β response
Kim, S. S.-Y., Sze, L., & Lam, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005868 · Cited by 134
Raaben, M., Koerkamp, M. J. A. G., Rottier, P. J. M., & de Haan, C. A. M. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00951.x · Cited by 133
Petit, C. M., Chouljenko, V. N., Iyer, A. V., Colgrove, R., Farzan, M., Knipe, D. M., & Kousoulas, K. G. (2006) · Virology · doi:10.1016/j.virol.2006.10.034 · Cited by 133
Penn, B. H., Netter, Z., Johnson, J. R., Dollen, J. V., Jang, G. Μ., Johnson, T. L., Ohol, Y. M., Maher, C., Bell, S. L., Geiger, K. M., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.010 · Cited by 130
Self-citationMycophenolic Acid: an Anti-cancer Compound with Unusual Properties
CARTER, S. B., Franklin, T. J., Jones, D., LEONARD, B. J., MILLS, S. D., Turner, R., & Turner, W. B. (1969) · Nature · doi:10.1038/223848a0 · Cited by 122
Oxazolidinones Inhibit Cellular Proliferation via Inhibition of Mitochondrial Protein Synthesis
Nagiec, E. E., Wu, L., Swaney, S. M., Chosay, J. G., Ross, D., Brieland, J. K., & Leach, K. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3896-3902.2005 · Cited by 120
Kanke, T., Macfarlane, S. R., Seatter, M. J., Davenport, E. L., Paul, A., McKenzie, R. C., & Plevin, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100377200 · Cited by 117
Xu, L., Chen, Y., Mayakonda, A., Koh, L., Chong, Y. K., Buckley, D. L., Sandanaraj, E., Lim, S. W., Lin, R. Y., Ke, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712363115 · Cited by 117
Nakagawa, K., Narayanan, K., Wada, M., & Makino, S. (2018) · Journal of Virology · doi:10.1128/jvi.00902-18 · Cited by 117
Novel Agonists and Antagonists for Human Protease Activated Receptor 2
Barry, G. D., Suen, J. Y., Le, G. T., Cotterell, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100984y · Cited by 115
Azzariti, A., Colabufo, N. A., Berardi, F., Porcelli, L., Niso, M., Simone, G. M., Perrone, R., & Paradiso, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0402 · Cited by 112
Kinetic studies of chromaffin granule H+-ATPase and effects of bafilomycin A1
Hanada, H., Moriyama, Y., Maeda, M., & Futai, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92172-v · Cited by 111
Dewe, J. M., Fuller, B. L., Lentini, J. M., Kellner, S. M., & Fu, D. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00214-17 · Cited by 109
Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
Cencic, R., Desforges, M., Hall, D. R., Kozakov, D., Du, Y., Min, J., Dingledine, R. J., Fu, H., Vajda, S., Talbot, P. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00078-11 · Cited by 108
Yang, W., Ru, Y., Ren, J., Bai, J., Wei, J., Fu, S., Liu, X., Li, D., & Zheng, H. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2178-9 · Cited by 107
Self-citationTetsuka, T., Uranishi, H., Imai, H., Ono, T., Sonta, S., Takahashi, N., Asamitsu, K., & Okamoto, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4383 · Cited by 103
Cullin E3 Ligases and Their Rewiring by Viral Factors
Mahon, C., Krogan, N., Craik, C., & Pick, E. (2014) · Biomolecules · doi:10.3390/biom4040897 · Cited by 101
Self-citationMultiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network
Eckhardt, M., Zhang, W., Gross, A. M., Dollen, J. V., Johnson, J. R., Franks-Skiba, K. E., Swaney, D. L., Johnson, T. L., Jang, G. Μ., Shah, P. S., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1018 · Cited by 101
Self-citationReineke, L. C., Tsai, W.-C., Jain, A., Kaelber, J. T., Jung, S. Y., & Lloyd, R. E. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00596-16 · Cited by 100
Sigma-1Rs are upregulated via PERK/eIF2α/ATF4 pathway and execute protective function in ER stress
Mitsuda, T., Omi, T., Tanimukai, H., Sakagami, Y., Tagami, S., Okochi, M., Kudo, T., & Takeda, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.113 · Cited by 97
Wittine, K., Babić, M. S., Makuc, D., Plavec, J., Pavelić, S. K., Sedić, M., Pavelić, K., Leyssen, P., Neyts, J. H., Balzarini, J. M., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.01.054 · Cited by 95
Li, M., Johnson, J. R., Truong, B., Kim, G. E., Weinbren, N. L., Dittmar, M., Shah, P. S., Dollen, J. V., Newton, B. W., Jang, G. Μ., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0375-z · Cited by 95
Self-citationTRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways
Kondo, T., Watanabe, M., & Hatakeyama, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.028 · Cited by 94
A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells
Martin, T. D., Cook, D. R., Choi, M. Y., Li, M. Z., Haigis, K. M., & Elledge, S. J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.061 · Cited by 94
Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics
Prussia, A. J., Thepchatri, P., Snyder, J. P., & Plemper, R. K. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12064027 · Cited by 91
Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
Fass, D. M., Shah, R. R., Ghosh, B., Hennig, K. M., Norton, S., Zhao, W., Reis, S. A., Klein, P. S., Mazitschek, R., Maglathlin, R. L., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml1001954 · Cited by 90
Enterovirus pathogenesis requires the host methyltransferase SETD3
Diep, J., Ooi, Y. S., Wilkinson, A. W., Peters, C. E., Foy, E. M., Johnson, J. R., Zengel, J. R., Ding, S., Weng, K., Laufman, O., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0551-1 · Cited by 88
Self-citationDiscovery of XL413, a potent and selective CDC7 inhibitor
Koltun, E. S., Tsuhako, A. L., Brown, D. S., Aay, N., Arcalas, A., Chan, V., Du, H., Engst, S., Ferguson, K., Franzini, M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.024 · Cited by 87
Self-citationMackman, R. L., Steadman, V. A., Dean, D. K., Jansa, P., Poullennec, K. G., Appleby, T. C., Austin, C., Blakemore, C. A., Cai, R. Z., Cannizzaro, C. E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00802 · Cited by 79
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships
Leung, L. M. H., Niculescu‐Duvaz, D., Smithen, D. A., Lopes, F., Callens, C., McLeary, R., Saturno, G., Davies, L. C., Aljarah, M., Brown, M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00335 · Cited by 77
Scoring Large‐Scale Affinity Purification Mass Spectrometry Datasets with MiST
Verschueren, E., Dollen, J. V., Cimermančič, P., Gulbahce, N., Šali, A., & Krogan, N. J. (2015) · Current Protocols in Bioinformatics · doi:10.1002/0471250953.bi0819s49 · Cited by 76
Self-citationRamasamy, S., Sáez, B., Mukhopadhyay, S., Ding, D., Ahmed, A. M., Chen, X., Pucci, F., Yamin, R., Wang, J., Pittet, M. J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511380113 · Cited by 76
Priebe, W., Krawczyk, M., Kuo, M. T., YAMANE, Y., Savaraj, N., & Ishikawa, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8887 · Cited by 74
Tesei, A., Cortesi, M., Zamagni, A., Arienti, C., Pignatta, S., Zanoni, M., Paolillo, M., Curti, D., Rui, M., Rossi, D., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00711 · Cited by 72
Vesiculoviral matrix (M) protein occupies nucleic acid binding site at nucleoporin pair (Rae1•Nup98)
Quan, B., Seo, H., Blobel, G., & Ren, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409076111 · Cited by 71
Gagliardi, S., Nadler, G., Consolandi, E., Parini, C., Morvan, M., Legave, M.-N., Belfiore, P., Zocchetti, A., Clarke, G. D., James, I. E., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800144 · Cited by 70
(R)- and (S)-Verapamil Differentially Modulate the Multidrug-resistant Protein MRP1
Perrotton, T., Trompier, D., Chang, X.-B., Pietro, A. D., & Baubichon-Cortay, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703964200 · Cited by 70
Rutaganira, F. U., Fowler, M. L., McPhail, J. A., Gelman, M. A., Nguyen, K., Xiong, A., Dornan, G. L., Tavshanjian, B., Glenn, J. S., Shokat, K. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01311 · Cited by 69
Self-citationNOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
Xu, P., Ye, S., Li, K., Huang, M., Wang, Q., Zeng, S., Chen, X., Gao, W., Chen, J., Zhang, Q., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1448-9 · Cited by 62
Self-citationCarelli, J. D., Sethofer, S. G., Smith, G. A., Miller, H., Simard, J. L., Merrick, W. C., Jain, R. K., Ross, N. T., & Taunton, J. (2015) · eLife · doi:10.7554/elife.10222 · Cited by 60
Self-citationIMPDH2 Is an Intracellular Target of the Cyclophilin A and Sanglifehrin A Complex
Pua, K. H., Stiles, D. T., Sowa, M. E., & Verdine, G. L. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.030 · Cited by 58
Slaine, P. D., Kleer, M., Smith, N. K., Khaperskyy, D. A., & McCormick, C. (2017) · Viruses · doi:10.3390/v9120388 · Cited by 54
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Llona‐Minguez, S., Höglund, A., Jacques, S. A., Johansson, L., Calderón‐Montaño, J. M., Claesson, M., Loseva, O., Valerie, N. C. K., Lundbäck, T., Piedrafita, F. J., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01741 · Cited by 53
McIver, E. G., Bryans, J. S., Birchall, K., Chugh, J., Drake, T., Lewis, S. J., Osborne, J., Smiljanic-Hurley, E., Tsang, W., Kamal, A. M., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.063 · Cited by 51
The Pharmacology of the Novel and Selective Sigma Ligand, PD 144418
Akunne, H. C., Whetzel, S. Z., Wiley, J. N., Corbin, A., Ninteman, F. W., Tecle, H., PEI, Y., Pugsley, T. A., & Heffner, T. G. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00161-x · Cited by 50
Ranadheera, C., Coombs, K. M., & Kobasa, D. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.05.027 · Cited by 49
Jorquera, P. A., Mathew, C., Pickens, J. A., Williams, C., Luczo, J. M., Tamir, S., Ghildyal, R., & Tripp, R. A. (2018) · Journal of Virology · doi:10.1128/jvi.01684-18 · Cited by 47
Santi, C. D., Giulianotti, P. C., Pietrabissa, A., Mosca, F., & Pacifici, G. M. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050448 · Cited by 46
Dabrafenib inhibits the growth of BRAF‐WT cancers through CDK16 and NEK9 inhibition
Phadke, M. A., Rix, L. L. R., Smalley, I., Bryant, A. T., Luo, Y., Lawrence, H. R., Schaible, B., Chen, Y. A., Rix, U., & Smalley, K. S. M. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12152 · Cited by 46
Discovery of Potent and Selective Small-Molecule PAR-2 Agonists
Seitzberg, J. G., Knapp, A. E., Lund, B. W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800754r · Cited by 39
Toral‐Barza, L., Zhang, W., Lamison, C., LaRocque, J., Gibbons, J. J., & Yu, K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.117 · Cited by 38
Hägglund, M. G. A., Roshanbin, S., Löfqvist, E., Hellsten, S. V., Nilsson, V. C., Todkar, A., Zhu, Y., Stephansson, O., Drgonová, J., Uhl, G. R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058651 · Cited by 36
Novel Sigma Receptor Ligands: Synthesis and Biological Profile
Prezzavento, O., Campisi, A., Ronsisvalle, S., Volti, G. L., Marrazzo, A., Bramanti, V., Cannavò, G., Vanella, L., Cagnotto, A., Mennini, T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0611197 · Cited by 35
Ma, J., Zhang, X., Soloveva, V., Warren, T. K., Guo, F., Wu, S., Lu, H., Guo, J., Su, Q., Shen, H. L., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.008 · Cited by 34
Self-citationSheahan, T. P., Sims, A. M., Zhou, S., Graham, R. L., Hill, C. S., Leist, S. R., Schäfer, A., Dinnon, K. H., Montgomery, S. A., Agostini, M. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.19.997890 · Cited by 31
A Quantitative Genetic Interaction Map of HIV Infection
Gordon, D. E., Watson, A., Roguev, A., Zheng, S., Jang, G. Μ., Kane, J., Xu, J., Guo, J. Z., Stevenson, E. J., Swaney, D. L., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.004 · Cited by 29
Self-citationIdentification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1
Llona‐Minguez, S., Höglund, A., Wiita, E., Almlöf, I., Mateus, A., Calderón‐Montaño, J. M., Cázares-Körner, C., Homan, E. J., Loseva, O., Baranczewski, P., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01786 · Cited by 27
LARP1 is a major phosphorylation substrate of mTORC1Preprint
Fonseca, B. D., Jia, J.-J., Hollensen, A. K., Pointet, R., Hoang, H., Niklaus, M., Pena, I. A., Lahr, R. M., Smith, E. M., Hearnden, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/491274 · Cited by 11
Thompson, P. A., Eam, B., Young, N. P., Fish, S., Chen, J. W., Barrera, M., Howard, H., Sung, E., Parra, A., Staunton, J., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-2698 · Cited by 5
Research works printed but not linked: 15
- SARS-CoV-2 infected host cell proteomics reveal potential therapy targets. In Review (2020).
- 10.21203/rs.3.rs-17218/v1 · DOI
- 10.1073/pnas.1812588116 · doi:10.1073/pnas.1812588116
- 10.1007/s13238-018-0554-3 · doi:10.1007/s13238-018-0554-3
- 10.1128/AAC.44.4.859-866.2000 · doi:10.1128/aac.44.4.859-866.2000
- 2012, CK2α and CK2α’ subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives, Eur. J. Med. Chem, 47, 345, 10.1016/j.ejmech.2011.11.002 · doi:10.1016/j.ejmech.2011.11.002
- 2010, Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin, ACS Med. Chem. Lett, 2, 39
- 10.1016/S0162-3109(00)00193-4 · doi:10.1016/s0162-3109(00)00193-4
- 2017, Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems, Bioorg. Med. Chem. Lett, 27, 3219, 10.1016/j.bmcl.2017.06.039 · doi:10.1016/j.bmcl.2017.06.039
- Thompson, P. A. et al. Abstract 2698: eFT226, a potent and selective inhibitor of eIF4A, is efficacious in preclinical models of lymphoma. in Experimental and Molecular Therapeutics 2698–2698 (American Association for Cancer Research, 2019). · DOI
- 10.1006/geno.1998.5571 · DOI
- 2017, Ester Prodrugs of IHVR-19029 with Enhanced Oral Exposure and Prevention of Gastrointestinal Glucosidase Interaction, ACS Med. Chem. Lett, 8, 157, 10.1021/acsmedchemlett.6b00332 · doi:10.1021/acsmedchemlett.6b00332
- 10.1124/mol.51.6.1070 · doi:10.1124/mol.51.6.1070
- 10.1101/2020.01.31.929042 · DOI
- 10.1021/jm3012992 · doi:10.1021/jm3012992
Cited by
GraphDTA: predicting drug–target binding affinity with graph neural networks
Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa921 · Cited by 1,220
Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., Gallo, R. C., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02344-6 · Cited by 996
Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
van Dorp, L., Acman, M., Richard, D., Shaw, L. P., Ford, C. E., Ormond, L., Owen, C. J., Pang, J., Tan, C. C. S., Boshier, F. A. T., et al. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104351 · Cited by 774
Sharma, A., Ahmad Farouk, I., & Lal, S. K. (2021) · Viruses · doi:10.3390/v13020202 · Cited by 703
Identification of SARS-CoV-2 inhibitors using lung and colonic organoids
Han, Y., Duan, X., Yang, L., Nilsson-Payant, B. E., Wang, P., Duan, F., Tang, X., Yaron, T. M., Zhang, T., Uhl, S., et al. (2021) · Nature · doi:10.1038/s41586-020-2901-9 · Cited by 530
Metadata
- Authors
- Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Huettenhain, R., Kaake, R. M., Richards, A. L., Tutuncuoglu, B., Foussard, H., Batra, J., Haas, K., Modak, M., Kim, M., Haas, P., Polacco, B. J., Braberg, H., Fabius, J. M., Eckhardt, M., Soucheray, M., Bennett, M. J., Cakir, M., McGregor, M. J., Li, Q., Naing, Z. Z. C., Zhou, Y., Peng, S., Kirby, I. T., Melnyk, J. E., Chorba, J. S., Lou, K., Dai, S. A., Shen, W., Shi, Y., Zhang, Z., Barrio-Hernandez, I., Memon, D., Hernandez-Armenta, C., Mathy, C. J. P., Perica, T., Pilla, K. B., Ganesan, S. J., Saltzberg, D. J., Ramachandran, R., Liu, X., Rosenthal, S. B., Calviello, L., Venkataramanan, S., Liboy-Lugo, J., Lin, Y., Wankowicz, S. A., Bohn, M., Sharp, P. P., Trenker, R., Young, J. M., Cavero, D. A., Hiatt, J., Roth, T. L., Rathore, U., Subramanian, A., Noack, J., Hubert, M., Roesch, F., Vallet, T., Meyer, B., White, K. M., Miorin, L., Rosenberg, O. S., Verba, K. A., Agard, D., Ott, M., Emerman, M., Ruggero, D., García-Sastre, A., Jura, N., von Zastrow, M., Taunton, J., Ashworth, A., Schwartz, O., Vignuzzi, M., d’Enfert, C., Mukherjee, S., Jacobson, M., Malik, H. S., Fujimori, D. G., Ideker, T., Craik, C. S., Floor, S., Fraser, J. S., Gross, J., Sali, A., Kortemme, T., Beltrao, P., Shokat, K., Shoichet, B. K., & Krogan, N. J.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-03-22
- OpenAlex
- W3012652877
- Cited by
- 395
- References
- 163
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.